Percutaneous Valvular and Structural Heart Disease Interventions. 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in Collaboration with the European Association of Cardiovascular...

The percutaneous treatment of structural, valvular, and non-valvular heart disease (SHD) is rapidly evolving. The Core Curriculum (CC) proposed by the EAPCI describes the knowledge, skills, and attitudes that define competency levels required by newly trained SHD interventional cardiologists (IC) and provides guidance for training centres. SHD ICs are cardiologists who have received complete interventional cardiology training. They are multidisciplinary team specialists who manage adult SHD patients from diagnosis to follow-up and perform percutaneous procedures in this area. They are competent in interpreting advanced imaging techniques and master planning software. The SHD ICs are expected to be proficient in the aortic, mitral, and tricuspid areas. They may have selective skills in either the aortic area or mitral/tricuspid areas. In this case, they must still have common transversal competencies in the aortic, mitral, and tricuspid areas. Additional SHD domain competencies are optional. Completing dedicated SHD training, aiming for full aortic, mitral, and tricuspid competencies, requires at least 18 months. For full training in the aortic area, with basic competencies in mitral/tricuspid areas, the training can be reduced to 1 year. The same is true for training in the mitral/tricuspid area, with competencies in the aortic area. The SHD IC CC promotes excellence and homogeneous training across Europe and is the cornerstone of future certifications and patient protection. It may be a reference for future CC for national associations and other SHD specialities, including imaging and cardiac surgery.

References

Lorenzoni V, Barbieri G, Saia F, Meucci F, Martinelli G, Cerillo A . The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups. Eur J Health Econ. 2021; 22(9):1349-1363. PMC: 8558181. DOI: 10.1007/s10198-021-01314-z. View

Pongiglione B, Torbica A, Blommestein H, de Groot S, Ciani O, Walker S . Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal. Int J Technol Assess Health Care. 2021; 37(1):e62. DOI: 10.1017/S0266462321000301. View

Carlhed R, Bojestig M, Peterson A, Aberg C, Garmo H, Lindahl B . Improved clinical outcome after acute myocardial infarction in hospitals participating in a Swedish quality improvement initiative. Circ Cardiovasc Qual Outcomes. 2009; 2(5):458-64. DOI: 10.1161/CIRCOUTCOMES.108.842146. View

Bavaria J, Tommaso C, Brindis R, Carroll J, Deeb G, Feldman T . 2018 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Aortic Valve Replacement: A Joint Report of the American Association for Thoracic Surgery, American.... J Am Coll Cardiol. 2018; 73(3):340-374. DOI: 10.1016/j.jacc.2018.07.002. View

Saad A, Kassis N, Isogai T, Gad M, Ahuja K, Abdelfattah O . Trends in Outcomes of Transcatheter and Surgical Aortic Valve Replacement in the United States (2012-2017). Am J Cardiol. 2020; 141:79-85. DOI: 10.1016/j.amjcard.2020.10.065. View

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J . 2021 ESC/EACTS Guidelines for the management of valvular heart disease. EuroIntervention. 2021; 17(14):e1126-e1196. PMC: 9725093. DOI: 10.4244/EIJ-E-21-00009. View

Tanner F, Brooks N, Fox K, Goncalves L, Kearney P, Michalis L . ESC Core Curriculum for the Cardiologist. Eur Heart J. 2020; 41(38):3605-3692. DOI: 10.1093/eurheartj/ehaa641. View

Ocagli H, Lorenzoni G, Lanera C, Schiavo A, DAngelo L, Liberti A . Monitoring Patients Reported Outcomes after Valve Replacement Using Wearable Devices: Insights on Feasibility and Capability Study: Feasibility Results. Int J Environ Res Public Health. 2021; 18(13). PMC: 8297062. DOI: 10.3390/ijerph18137171. View

Van Belle E, Vincent F, Labreuche J, Auffret V, Debry N, Lefevre T . Balloon-Expandable Versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison From the FRANCE-TAVI Registry. Circulation. 2019; 141(4):243-259. DOI: 10.1161/CIRCULATIONAHA.119.043785. View

10.

Agricola E, Ancona F, Brochet E, Donal E, Dweck M, Faletra F . The structural heart disease interventional imager rationale, skills and training: a position paper of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2021; 22(5):471-479. DOI: 10.1093/ehjci/jeab005. View

11.

Bekeredjian R, Szabo G, Balaban U, Bleiziffer S, Bauer T, Ensminger S . Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY). Eur Heart J. 2018; 40(17):1323-1330. DOI: 10.1093/eurheartj/ehy699. View

12.

Van Belle E, Teles R, Pyxaras S, Kalpak O, Johnson T, Barbash I . EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of the European Society of Cardiology. EuroIntervention. 2020; 17(1):23-31. PMC: 9725044. DOI: 10.4244/EIJ-D-18-00448. View

13.

Leonardi S, Capodanno D, Sousa-Uva M, Vrints C, Rex S, Guarracino F . Composition, structure, and function of heart teams: a joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization. Eur Heart J Acute Cardiovasc Care. 2021; 10(1):83-93. DOI: 10.1093/ehjacc/zuaa013. View

14.

Kappetein A, Head S, Genereux P, Piazza N, Van Mieghem N, Blackstone E . Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J. 2012; 33(19):2403-18. DOI: 10.1093/eurheartj/ehs255. View

15.

Baumgartner H, Falk V, Bax J, De Bonis M, Hamm C, Holm P . 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36):2739-2791. DOI: 10.1093/eurheartj/ehx391. View

16.

Genereux P, Piazza N, Alu M, Nazif T, Hahn R, Pibarot P . Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J. 2021; 42(19):1825-1857. DOI: 10.1093/eurheartj/ehaa799. View

17.

Flynn M, Barrett C, Cosio F, Gitt A, Wallentin L, Kearney P . The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice. Eur Heart J. 2004; 26(3):308-13. DOI: 10.1093/eurheartj/ehi079. View

18.

Parma R, Zembala M, Dabrowski M, Jagielak D, Witkowski A, Suwalski P . Transcatheter aortic valve implantation. Expert Consensus of the Association of Cardiovascular Interventions of the Polish Cardiac Society and the Polish Society of Cardio-Thoracic Surgeons, approved by the Board of the Polish Cardiac Society…. Kardiol Pol. 2017; 75(9):937-964. DOI: 10.5603/KP.2017.0175. View

19.

Loureiro-Ga M, Veiga C, Fdez-Manin G, Jimenez V, Juan-Salvadores P, Busto L . Predicting TAVI paravalvular regurgitation outcomes based on numerical simulation of the aortic annulus eccentricity and perivalvular areas. Comput Methods Biomech Biomed Engin. 2021; 24(14):1629-1637. DOI: 10.1080/10255842.2021.1906233. View